PIP
XBI icon

Philadelphia Investment Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Philadelphia Investment Partners’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$974K Sell
6,151
-66
-1% -$8.92K 0.61% 36
2026
Q1 		$794K Buy
+6,217
New +$776K 0.54% 37

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Philadelphia Investment Partners's XBI Position: Q2 2026 in Review

Philadelphia Investment Partners reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.1% in Q2 2026, selling an estimated $8.92K and leaving 6,151 shares worth $974K. The position accounts for 0.61% of the portfolio, ranked #36.

Philadelphia Investment Partners first reported a position in XBI in Q1 2026 and has held it in 2 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Philadelphia Investment Partners held 6,151 shares of State Street SPDR S&P Biotech ETF worth $974K as of Q2 2026.
  • Philadelphia Investment Partners sold 66 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $8.92K.
  • State Street SPDR S&P Biotech ETF made up 0.61% of Philadelphia Investment Partners's portfolio in Q2 2026, its #36 holding.
  • Philadelphia Investment Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2026 and has held it in 2 quarters since.
  • 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Philadelphia Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.